 treatment migrain attack sumatriptan subcutan sumatriptan intern studi group background headach migrain attack dilat certain cranial arteri arterioven anastomos neurogen dural plasma extravas mechan sumatriptan novel select agonist receptor block phenomena efficaci migrain method patient migrain attack random double-blind placebo-control parallel-group clinic trial effect subcutan inject mg sumatriptan placebo sever headach migran symptom minut treatment patient free pain minut placebo placebo mg sumatriptan mg sumatriptan placebo mg sumatriptan result minut sever headach percent percent confid interv percent patient mg sumatriptan percent percent confid interv percent patient mg sumatriptan percent percent confid interv percent patient placebo data patient placebo group percent percent confid interv percent patient mg sumatriptan percent percent confid interv percent patient mg sumatriptan decreas sever headach comparison minut percent patient sumatriptan mg placebo mg mg mg placebo improv sever headach percent patient placebo comparison patient analysi data protocol violat respons rate sumatriptan advers event minor transient group conclus singl dose sumatriptan effect rapid-act well-toler treatment migran attack administr second dose minut patient initi dose afford littl addit benefit